www.fdanews.com/articles/147218-dendreon-shareholders-complain-about-stock-losses
Dendreon Shareholders Complain About Stock Losses
June 14, 2012
Dendreon shareholders strafed the Seattle biotechnology company’s leadership with criticism at Wednesday’s annual meeting, upset at the stock’s 82 percent decline in the past year.
The Seattle Times
The Seattle Times